Bevacizumab induced intestinal perforation in patients with colorectal cancer
Sun Young Baek, Seung Hun Lee, Seung Hyun Lee
Korean J Clin Oncol. 2019;15(1):15-18. Published online 2019 Jun 30 DOI: https://doi.org/10.14216/kjco.19004
Citations to this article as recorded by 
Bevacizumab side effects and adverse clinical complications in colorectal cancer patients: review article
Rahmawati Minhajat, Tutik Harjianti, Itzar Chaidir Islam, Sanjaya Winarta, Yason Nikolaus Liyadi, Nabilah Putri Bamatraf, Rabbaniyah Amanuddin
Annals of Medicine & Surgery.2023; 85(8): 3931. CrossRef
Medications and the risk of perforated appendicitis: an adverse event report system (FAERS) database analysis
Daryl Ramai, Daniel Mozell, Antonio Facciorusso, Anjali Kewalramani, Saurabh Chandan, Banreet Dhindsa, Amaninder Dhaliwal, Shahab Khan, Douglas G. Adler
Expert Review of Gastroenterology & Hepatology.2022; 16(10): 1011. CrossRef
Unusual case of colorectal carcinoma with sarcoid-like mediastinal adenopathy and near-fatal DPD deficiency
Shakti Pillay, Owen Terreblanche, John Devar, Ashraf Wadee
South African Journal of Oncology.2021;[Epub] CrossRef
Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab
Ramesh Adhikari, Medha Ghose, Aysun Tekin, Simranjit Singh, Romil Singh
Cureus.2021;[Epub] CrossRef